WASHINGTON (MedPage Today) — For the second time this year, the Centers for Medicare and Medicaid Services (CMS) has stepped in, effectively forestalling the 21% cut in Medicare reimbursement set to take effect on April 1.
No Comments »
Filed under: General Health News
ALEXANDRIA, Va. (MedPage Today) — President Obama has signed the health reform reconciliation bill, marking the end of a year-long battle to reform the health insurance system.
No Comments »
Filed under: General Health News
Patents on BRCA1/2 gene sequences associated with breast cancer risk (MedPage Today) — and by extension all other human genes — are inherently invalid, a federal district judge ruled.
No Comments »
Filed under: General Health News
Only one person in 40 has an extraordinary ability to do safely what many take for granted in daily life (MedPage Today) — talk on a cell phone while driving.
No Comments »
Filed under: General Health News
Animal experiments routinely fail to predict results in clinical trials (MedPage Today) — a problem that could be avoided with stricter research standards, researchers said.
No Comments »
Filed under: General Health News
Nymox Pharmaceutical Corporation outlined today the Company’s development program for the Company’s lead drug candidate, NX-1207, currently in Phase 3 trials in the U.S. for the treatment of benign prostatic hyperplasia (BPH). The drug has been successful in a series of blinded controlled multi-center U.S. clinical trials where it has been found to produce improvements [...]
No Comments »
Filed under: Pharmacy News
PolyMedix, Inc., an emerging bio-technology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has successfully completed a Phase 1B clinical study with its novel defensin-mimetic antibiotic, PMX-30063. The data from the study demonstrate that administration of multiple doses of PMX-30063 are safe and well-tolerated at dose levels which [...]
No Comments »
Filed under: Pharmacy News
QRxPharma announced today initiation of the Company’s first Phase 1 trial to evaluate the pharmacokinetic (PK) profiles of experimental controlled-release (CR) morphine and oxycodone formulations that will be incorporated into MoxDuo®CR. MoxDuo®CR contains a fixed 3:2 morphine:oxycodone combination and is intended to be dosed twice daily in patients experiencing chronic pain, an approximately US$7 [...]
No Comments »
Filed under: Pharmacy News
YM BioSciences Inc., announced that it has received ethics board approval to expand enrolment in its Phase I/II clinical trial of CYT387 at Mayo Clinic in patients with myelofibrosis, a chronic debilitating condition, where patient’s bone marrow is replaced by scar tissue.
No Comments »
Filed under: Pharmacy News
Titan Pharmaceuticals, Inc. today announced the initiation of a randomized, placebo and active controlled, multi-center Phase 3 clinical study of Probuphine in the treatment of opioid addiction. This confirmatory Phase 3 study will be conducted at approximately 23 sites in the United States and randomize approximately 250 patients into three arms: Probuphine (100 patients), Suboxone® [...]
No Comments »
Filed under: Pharmacy News
